Free Submission Public Relations &
Deutsch English


Now Available: Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2013 Update

Print article Print article
2014-01-16 16:51:40 - Fast Market Research recommends "Cancer Genetics, Inc. (CGIX) - Product Pipeline Analysis, 2013 Update" from GlobalData, now available

Cancer Genetics, Inc. (CGI) is a pharmaceutical company. The company offers DNA-based cancer diagnostics products and services. Its products include MatBA, UroGenRA, and FHACT. CGI's MatBA is a mature b-cell neoplasm array used in diagnosis and prognosis of non-Hodgkin lymphomas. The company's UroGenRA is an oligonucleotide array product that is developed to detect genomic copy number alterations with prognostic and diagnostic value in kidney, prostate and bladder cancers. Its FHACT is a FISH-based HPV-associated cancer test. The company provides clinical services such as test menu, complete program, and summation report. It collaborates with Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute. CGI is headquartered in New Jersey, the US.

Full Report Details at
- ..

This report

is a source for data, analysis and actionable intelligence on the Cancer Genetics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.


* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. * Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. * Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. * Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. * Data on relevant clinical trials and product patent details, wherever applicable. * Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally. * Design and develop your product development, marketing and sales strategies. * Exploit M&A opportunities by identifying market players with the most innovative pipeline. * Develop market-entry and market expansion strategies. * Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return. * Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. * Develop competition strategies by identifying the status and likely launch of your competitors' pipeline products through review of the clinical trials, stage and phase of development, etc. * Which are the next high-value products that your competitor would add in its portfolio? - identify, understand and capitalize.

Companies Mentioned in this Report: Cancer Genetics, Inc. (CGIX)

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact